Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002. New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-Blockers

Eur Urol Focus. 2021 May;7(3):662-663. doi: 10.1016/j.euf.2020.04.010. Epub 2020 May 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Lower Urinary Tract Symptoms* / drug therapy
  • Network Meta-Analysis
  • Prostatic Hyperplasia* / drug therapy
  • Serenoa
  • Treatment Outcome